Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies
Clin Lymphoma Myeloma Leuk
.
2022 Jul;22(7):e495-e497.
doi: 10.1016/j.clml.2022.01.010.
Epub 2022 Jan 19.
Authors
Meera Mohan
1
,
Sneha Nagavally
2
,
Nirav N Shah N
2
,
Laura Michaelis
2
,
Saurabh Chhabra
2
,
Anita D Souza
2
,
Sameem Abedin
2
,
Lyndsey Runaas
2
,
Guru Subramanian Guru Murthy
2
,
Walter Longo
2
,
Mehdi Hamadani
2
,
Binod Dhakal
2
,
Parameswaran Hari
2
,
Timothy S Fenske
2
Affiliations
1
Department of Internal Medicine, Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI. Electronic address:
[email protected]
.
2
Department of Internal Medicine, Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI.
PMID:
35148976
PMCID:
PMC8767926
DOI:
10.1016/j.clml.2022.01.010
No abstract available
Publication types
Letter
MeSH terms
COVID-19* / prevention & control
Hematologic Neoplasms* / therapy
Humans
Immunization
Seroconversion
Vaccination